Cargando…

Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures

Disturbances in the circadian rhythm alter the normal sleep-wake cycle, which increases vulnerability to drug abuse. Drug abuse can disrupt several homeostatic processes regulated by the circadian rhythm and influence addiction paradigms, including cravings for cocaine. The relationship between circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Doke, Mayur, McLaughlin, Jay P., Baniasadi, Hamid, Samikkannu, Thangavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502494/
https://www.ncbi.nlm.nih.gov/pubmed/36144274
http://dx.doi.org/10.3390/metabo12090869
_version_ 1784795719651033088
author Doke, Mayur
McLaughlin, Jay P.
Baniasadi, Hamid
Samikkannu, Thangavel
author_facet Doke, Mayur
McLaughlin, Jay P.
Baniasadi, Hamid
Samikkannu, Thangavel
author_sort Doke, Mayur
collection PubMed
description Disturbances in the circadian rhythm alter the normal sleep-wake cycle, which increases vulnerability to drug abuse. Drug abuse can disrupt several homeostatic processes regulated by the circadian rhythm and influence addiction paradigms, including cravings for cocaine. The relationship between circadian rhythm and cocaine abuse is complex and bidirectional, and disruption impacts both brain function and metabolic profiles. Therefore, elucidating the impact of circadian rhythm changes and cocaine abuse on the human metabolome may provide new insights into identifying potential biomarkers. We examine the effect of cocaine administration with and without circadian rhythm sleep disruption (CRSD) on metabolite levels and compare these to healthy controls in an in vivo study. A metabolomics analysis is performed on the control, CRSD, cocaine, and CRSD with cocaine groups. Plasma metabolite concentrations are analyzed using a liquid chromatography electrochemical array platform. We identify 242 known metabolites compared to the control; 26 in the CRSD with cocaine group, 4 in the CRSD group, and 22 in the cocaine group are significantly differentially expressed. Intriguingly, in the CRSD with cocaine treatment group, the expression levels of uridine monophosphate (p < 0.008), adenosine 5′-diphosphate (p < 0.044), and inosine (p < 0.019) are significantly altered compared with those in the cocaine group. In summary, alterations in purine and pyrimidine metabolism provide clues regarding changes in the energy profile and metabolic pathways associated with chronic exposure to cocaine and CRSD.
format Online
Article
Text
id pubmed-9502494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95024942022-09-24 Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures Doke, Mayur McLaughlin, Jay P. Baniasadi, Hamid Samikkannu, Thangavel Metabolites Article Disturbances in the circadian rhythm alter the normal sleep-wake cycle, which increases vulnerability to drug abuse. Drug abuse can disrupt several homeostatic processes regulated by the circadian rhythm and influence addiction paradigms, including cravings for cocaine. The relationship between circadian rhythm and cocaine abuse is complex and bidirectional, and disruption impacts both brain function and metabolic profiles. Therefore, elucidating the impact of circadian rhythm changes and cocaine abuse on the human metabolome may provide new insights into identifying potential biomarkers. We examine the effect of cocaine administration with and without circadian rhythm sleep disruption (CRSD) on metabolite levels and compare these to healthy controls in an in vivo study. A metabolomics analysis is performed on the control, CRSD, cocaine, and CRSD with cocaine groups. Plasma metabolite concentrations are analyzed using a liquid chromatography electrochemical array platform. We identify 242 known metabolites compared to the control; 26 in the CRSD with cocaine group, 4 in the CRSD group, and 22 in the cocaine group are significantly differentially expressed. Intriguingly, in the CRSD with cocaine treatment group, the expression levels of uridine monophosphate (p < 0.008), adenosine 5′-diphosphate (p < 0.044), and inosine (p < 0.019) are significantly altered compared with those in the cocaine group. In summary, alterations in purine and pyrimidine metabolism provide clues regarding changes in the energy profile and metabolic pathways associated with chronic exposure to cocaine and CRSD. MDPI 2022-09-15 /pmc/articles/PMC9502494/ /pubmed/36144274 http://dx.doi.org/10.3390/metabo12090869 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Doke, Mayur
McLaughlin, Jay P.
Baniasadi, Hamid
Samikkannu, Thangavel
Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title_full Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title_fullStr Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title_full_unstemmed Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title_short Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures
title_sort sleep disorder and cocaine abuse impact purine and pyrimidine nucleotide metabolic signatures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502494/
https://www.ncbi.nlm.nih.gov/pubmed/36144274
http://dx.doi.org/10.3390/metabo12090869
work_keys_str_mv AT dokemayur sleepdisorderandcocaineabuseimpactpurineandpyrimidinenucleotidemetabolicsignatures
AT mclaughlinjayp sleepdisorderandcocaineabuseimpactpurineandpyrimidinenucleotidemetabolicsignatures
AT baniasadihamid sleepdisorderandcocaineabuseimpactpurineandpyrimidinenucleotidemetabolicsignatures
AT samikkannuthangavel sleepdisorderandcocaineabuseimpactpurineandpyrimidinenucleotidemetabolicsignatures